Biotech

All Articles

Zephyrm seeks Hong Kong IPO to cash period 3 tissue therapy tests

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock exchange, submitting (PDF) for a...

Frazier Lifestyle Sciences gets $630M for little, mid-cap biotechs

.Frazier Life Sciences has sourced a further $630 thousand for its own fund paid attention to little...

GigaGen garners approximately $135M BARDA dollars to beat botulism

.Antibody connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its technician...

GPCR organization Septerna declare IPO on durability of preclinical information

.Septerna will determine just how a biotech without "any sort of purposeful clinical data" meals in ...

Kurma closes to begin with $154M haul for largest biotech fund yet

.European VC company Kurma Allies has actually revealed its most current biotech fund, along with 14...

Prothena advertises one exec while one more keeps-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and ret...

Editas cashes in on Vertex Cas9 licensing rights for $57M

.Against the backdrop of a Cas9 license fight that declines to die, Editas Medicine is cashing in a ...

Ultragenyx fine-tunes genetics therapy application to dial up effectiveness

.A minority of people taking Ultragenyx Drug's Wilson disease genetics treatment UX701 have actually...

Biopharma layoff cost supports in Q3: Tough Biotech analysis

.As summer season heat looks to cool winds, really hopes that this year will deliver common business...

J &amp J loses phase 2 dengue candidate in latest change coming from vaccinations

.Johnson &amp Johnson's deprioritization of its transmittable condition pipe has stated yet another ...